Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» REGN727
REGN727
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Pfizer
PCSK9 inhibitors
RN-316
Sanofi
Regeneron
REGN727
AMG145
Amgen
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Regeneron cholesterol drug faces sudden challenge
Reuters
Mon, 03/26/12 - 12:10 pm
Amgen
Regeneron
PCSK9 inhibitor
AMG145
REGN727
Sanofi
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727